Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$40,000.00

Novel strategy to intercept pathogens at the site of cellular entry

FY 2011-12

Summary
In eukaryotic cells the delivery of newly synthesized proteins to the endosomes and lysosomes and to the cell surface is dependent on a unique organelle, the ""Golgi apparatus"", which sorts and targets proteins to their final destination. Proteins delivered to the endosomes and lysosomes include a large and diverse class of hydrolytic enzymes and nonenzymic activator proteins. They are directed away via two mannose-6-phosphate receptors (MPRs). Recently, we found that the lysosomal activator protein ""prosaposin"" traffics to the endosomes and lysosomes using the alternative sorting receptor, ""sortilin"". We also found that deletion of the terminal segment of prosaposin abolished its transport to the endosomes and lysosomes. Mutational analysis allowed us to identify that a small segment within the so-called prosaposin ""C-terminus"" contains a unique motif required for its binding to sortilin and its transport to the endosomes and lysosomes. The identified sequence may permit the development of new therapeutic approaches for the targeting of proteins with anti-pathogenic properties to the endosomes and lysosomes. Given that most of the known pathogens penetrate the cell via the endocytic pathway at the endosomes and lysosomes, our approach may be useful to destroy the pathogens within these compartments. Thus, the present research may establish a proof of concept and offer alternative treatments for infectious diseases in animals and humans for which there are no treatment available.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
183639-2011
Name nom
Morales, Carlos
Department département
Anatomy and Cell Biology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Partie
1
Nb partie
1
Application title
Novel strategy to intercept pathogens at the site of cellular entry
Keyword
NSERC
Application summary
In eukaryotic cells the delivery of newly synthesized proteins to the endosomes and lysosomes and to the cell surface is dependent on a unique organelle, the ""Golgi apparatus"", which sorts and targets proteins to their final destination. Proteins delivered to the endosomes and lysosomes include a large and diverse class of hydrolytic enzymes and nonenzymic activator proteins. They are directed away via two mannose-6-phosphate receptors (MPRs). Recently, we found that the lysosomal activator protein ""prosaposin"" traffics to the endosomes and lysosomes using the alternative sorting receptor, ""sortilin"". We also found that deletion of the terminal segment of prosaposin abolished its transport to the endosomes and lysosomes. Mutational analysis allowed us to identify that a small segment within the so-called prosaposin ""C-terminus"" contains a unique motif required for its binding to sortilin and its transport to the endosomes and lysosomes. The identified sequence may permit the development of new therapeutic approaches for the targeting of proteins with anti-pathogenic properties to the endosomes and lysosomes. Given that most of the known pathogens penetrate the cell via the endocytic pathway at the endosomes and lysosomes, our approach may be useful to destroy the pathogens within these compartments. Thus, the present research may establish a proof of concept and offer alternative treatments for infectious diseases in animals and humans for which there are no treatment available.